- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 52 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.4: 15 residues within 4Å:- Chain A: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain B: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.1, POV.5, POV.6, POV.8
9 PLIP interactions:6 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:I.969, A:F.970, A:F.970, B:W.1070, B:W.1070, B:L.1071
- Hydrogen bonds: A:Y.922, A:S.926, A:S.926
CLR.21: 15 residues within 4Å:- Chain B: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain C: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.18, POV.22, POV.24, POV.33
10 PLIP interactions:4 interactions with chain C, 6 interactions with chain B- Hydrophobic interactions: C:W.1070, C:W.1070, C:L.1071, C:L.1075, B:I.969, B:F.970, B:F.970
- Hydrogen bonds: B:Y.922, B:S.926, B:S.926
CLR.37: 15 residues within 4Å:- Chain C: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain D: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.34, POV.38, POV.40, POV.52
11 PLIP interactions:6 interactions with chain C, 5 interactions with chain D- Hydrophobic interactions: C:I.969, C:F.970, C:F.970, D:W.1070, D:W.1070, D:L.1071, D:F.1074, D:V.1078
- Hydrogen bonds: C:Y.922, C:S.926, C:S.926
CLR.56: 15 residues within 4Å:- Chain A: W.1070, L.1071, F.1074, L.1075, V.1078
- Chain D: Y.922, S.926, L.966, I.969, F.970, V.973
- Ligands: POV.17, POV.53, POV.57, POV.59
10 PLIP interactions:4 interactions with chain A, 6 interactions with chain D- Hydrophobic interactions: A:W.1070, A:W.1070, A:L.1071, A:L.1075, D:I.969, D:F.970, D:F.970
- Hydrogen bonds: D:Y.922, D:S.926, D:S.926
- 4 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
DU0.13: 19 residues within 4Å:- Chain A: L.1011, V.1015, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Chain D: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Ligands: POV.6, POV.51, POV.63
7 PLIP interactions:3 interactions with chain D, 4 interactions with chain A- Hydrophobic interactions: D:T.870, D:F.871, D:Y.972, A:W.1029, A:A.1032, A:I.1035
- Hydrogen bonds: A:W.1029
DU0.29: 19 residues within 4Å:- Chain A: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain B: L.1011, V.1015, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.12, POV.16, POV.33
7 PLIP interactions:4 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:W.1029, B:A.1032, B:I.1035, A:T.870, A:F.871, A:Y.972
- Hydrogen bonds: B:W.1029
DU0.45: 18 residues within 4Å:- Chain B: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain C: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.28, POV.32, POV.52
7 PLIP interactions:4 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:W.1029, C:A.1032, C:I.1035, B:T.870, B:F.871, B:Y.972
- Hydrogen bonds: C:W.1029
DU0.64: 19 residues within 4Å:- Chain C: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain D: L.1011, V.1015, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.17, POV.44, POV.48
7 PLIP interactions:3 interactions with chain C, 4 interactions with chain D- Hydrophobic interactions: C:T.870, C:F.871, C:Y.972, D:W.1029, D:A.1032, D:I.1035
- Hydrogen bonds: D:W.1029
- 4 x ZY8: (4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-8aH-4,8-methanobis[1]benzofuro[3,2-e:2',3'-g]isoquinoline-1,8a-diol(Non-covalent)
ZY8.14: 16 residues within 4Å:- Chain A: F.855, D.921, F.923, R.974, D.977, F.978, A.980, V.981, V.989, M.990, W.1110, Q.1113, R.1114, F.1117, Y.1121
- Ligands: POV.1
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:F.855, A:F.923, A:F.978, A:A.980, A:V.989, A:F.1117, A:F.1117
- Hydrogen bonds: A:D.977, A:W.1110, A:Q.1113
- Salt bridges: A:D.977
ZY8.30: 16 residues within 4Å:- Chain B: F.855, D.921, F.923, R.974, D.977, F.978, A.980, V.981, V.989, M.990, W.1110, Q.1113, R.1114, F.1117, Y.1121
- Ligands: POV.18
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:F.855, B:F.923, B:F.978, B:A.980, B:V.989, B:F.1117, B:F.1117
- Hydrogen bonds: B:D.977, B:W.1110, B:Q.1113
- Salt bridges: B:D.977
ZY8.46: 16 residues within 4Å:- Chain C: F.855, D.921, F.923, R.974, D.977, F.978, A.980, V.981, V.989, M.990, W.1110, Q.1113, R.1114, F.1117, Y.1121
- Ligands: POV.34
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:F.855, C:F.923, C:F.978, C:A.980, C:V.989, C:F.1117, C:F.1117
- Hydrogen bonds: C:D.977, C:W.1110, C:Q.1113
- Salt bridges: C:D.977
ZY8.65: 16 residues within 4Å:- Chain D: F.855, D.921, F.923, R.974, D.977, F.978, A.980, V.981, V.989, M.990, W.1110, Q.1113, R.1114, F.1117, Y.1121
- Ligands: POV.53
11 PLIP interactions:11 interactions with chain D- Hydrophobic interactions: D:F.855, D:F.923, D:F.978, D:A.980, D:V.989, D:F.1117, D:F.1117
- Hydrogen bonds: D:D.977, D:W.1110, D:Q.1113
- Salt bridges: D:D.977
- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nadezhdin, K.D. et al., Structural mechanisms of TRPM7 activation and inhibition. Nat Commun (2023)
- Release Date
- 2023-05-17
- Peptides
- Transient receptor potential cation channel subfamily M member 7: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 52 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 4 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
- 4 x ZY8: (4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-8aH-4,8-methanobis[1]benzofuro[3,2-e:2',3'-g]isoquinoline-1,8a-diol(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nadezhdin, K.D. et al., Structural mechanisms of TRPM7 activation and inhibition. Nat Commun (2023)
- Release Date
- 2023-05-17
- Peptides
- Transient receptor potential cation channel subfamily M member 7: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.